Bed Time
Withdrawn from the US market on 13 February 2024 (according to the DSLD)
Herb Pharm Herbs on the Go, food supplement from the US market
Label withdrawn from the US market. Bed Time (Herb Pharm Herbs on the Go), a food supplement au code-barres 090700032104, is described by its US market label. The French and European rules we can apply to this label flag no particular point. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
If this product were sold in France
No point flagged by the rules we apply.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- Herb Pharm Herbs on the Go
- Barcode
- 090700032104
- Form
- Liquid
- One serving
- 0.7 ml
- Servings
- up to 4 servings per day
- Other ingredients (in English, as written)
- certified organic Cane Alcohol, distilled Water, certified organic Vegetable Glycerin
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Certified Organic Extract Blend | Blend | 697 mg |
| California Poppy extract (Eschscholzia californica) | Plant | not stated |
| Ziziphus extract | Plant | not stated |
| Lemon Balm extract (Melissa officinalis) | Plant | not stated |
| Passionflower extract (Passiflora incarnata) | Plant | not stated |
| Chamomile extract | Plant | not stated |
| Lavender extract (Lavandula angustifolia) | Plant | not stated |
| Cardamom extract | Plant | not stated |
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: Bed Time
Entered into DSLD on 22 October 2021. Withdrawn from the US market on 27 November 2023 (according to the DSLD).Same active composition.
Official label: Bed Time
Entered into DSLD on 22 May 2020. Withdrawn from the US market on 14 July 2021 (according to the DSLD).- Same quantity, different name: California Poppy whole flowering plant extract in this version; California Poppy extract on the displayed label (quantity not stated)
Official label: Bed Time
Entered into DSLD on 24 June 2019. Withdrawn from the US market on 24 February 2020 (according to the DSLD).- Same quantity, different name: California Poppy whole flowering plant extract in this version; California Poppy extract on the displayed label (quantity not stated)
Official label: Bed Time
Entered into DSLD on 25 April 2019. Withdrawn from the US market on 27 November 2018 (according to the DSLD).- Active ingredient added : California Poppy (quantity not stated)
- Active ingredient added : Chamomile (quantity not stated)
- Active ingredient added : Lavender (quantity not stated)
- Active ingredient added : Lemon Balm (quantity not stated)
- Active ingredient added : Passionflower (quantity not stated)
- Active ingredient added : Ziziphus (quantity not stated)
- Active ingredient removed : California Poppy extract (quantity not stated)
- Active ingredient removed : Chamomile extract (quantity not stated)
- Active ingredient removed : Lavender extract (quantity not stated)
- Active ingredient removed : Lemon Balm extract (quantity not stated)
- Active ingredient removed : Passionflower extract (quantity not stated)
- Active ingredient removed : Ziziphus extract (quantity not stated)
- Same quantity, different name: Proprietary Extract Blend in this version; Certified Organic Extract Blend on the displayed label (697 mg)
Official label: Bed Time
Entered into DSLD on 22 December 2017. Withdrawn from the US market on 17 July 2018 (according to the DSLD).- Active ingredient added : California Poppy (quantity not stated)
- Active ingredient added : Cardamom (quantity not stated)
- Active ingredient added : Chamomile (quantity not stated)
- Active ingredient added : Lavender (quantity not stated)
- Active ingredient added : Lemon Balm (quantity not stated)
- Active ingredient added : Passionflower (quantity not stated)
- Active ingredient added : Ziziphus (quantity not stated)
- Active ingredient removed : California Poppy extract (quantity not stated)
- Active ingredient removed : Cardamom extract (quantity not stated)
- Active ingredient removed : Chamomile extract (quantity not stated)
- Active ingredient removed : Lavender extract (quantity not stated)
- Active ingredient removed : Lemon Balm extract (quantity not stated)
- Active ingredient removed : Passionflower extract (quantity not stated)
- Active ingredient removed : Ziziphus extract (quantity not stated)
- Same quantity, different name: Proprietary Extract Blend in this version; Certified Organic Extract Blend on the displayed label (697 mg)
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- California Poppy extract
Read the warning, when it applies and the studies cited
CALIFORNIA POPPY - ESCHSCHOLZIA CALIFORNICA
Route of administration: Oral
Cautions and warnings
Condition of application: Sleep aid.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if sleeplessness persists continuously for more than 4 weeks (chronic insomnia) (Berardi et al. 2002; Dipiro et al. 2002).
Sources cited by Health Canada (2)
- Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA, Tietze KJ, editors. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13th edition. Washington (DC): American Pharmaceutical Association; 2002.
- Dipiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM. Pharmacotherapy: a pathophysiologic approach, 5th edition. New York (NY): The McGraw-Hill Companies, Inc.; 2002.
Condition of application: Other uses.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding (Brinker 2010; Mills and Bone 2005).
Sources cited by Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
When using this product avoid taking with alcohol or products that cause drowsiness and/or with analgesic properties (Brinker 2010; Mills and Bone 2005; Hoffmann 2003).
Sources cited by Health Canada (3)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Hoffmann D. Medical Herbalism. Rochester (VT): Healing Arts Press; 2003.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
When using this product exercise caution if you drive or use machinery as you may experience drowsiness (EMA 2015; Berardi et al. 2002).
Sources cited by Health Canada (2)
- Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA, Tietze KJ, editors. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13th edition. Washington (DC): American Pharmaceutical Association; 2002.
- EMA 2015: European Medicines Agency. European Union herbal monograph on Eschscholzia californica Cham., herba London. (UK): Committee on Herbal Medicinal Products (HMPC); 2015. [Accessed 2024 March 1]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-eschscholzia-californica-cham-herba_en.pdf.
Contraindications
Do not use if you are pregnant (Brinker 2010; Blumenthal et al. 2000).
Sources cited by Health Canada (2)
- Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications; 2000.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Lemon Balm extract
Read the warning, when it applies and the studies cited
LEMON BALM -MELISSA OFFICINALIS
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (EMA 2014).
Sources cited by Health Canada (1)
- EMA 2014. European Medicines Agency. Melissae folium.. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 16 June2014. [Accessed 2023 October 27]. Available at: https://www.ema.europa.eu/en/medicines/herbal/melissae-folium
When using this product exercise caution if you drive or use machinery as you may experience drowsiness (EMA 2014).
Sources cited by Health Canada (1)
- EMA 2014. European Medicines Agency. Melissae folium.. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 16 June2014. [Accessed 2023 October 27]. Available at: https://www.ema.europa.eu/en/medicines/herbal/melissae-folium
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
- Passionflower extract
Read the warning, when it applies and the studies cited
PASSIONFLOWER -PASSIFLORA INCARNATA
Route of administration: Oral
Cautions and warnings
Condition of application: Sleep aid.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if sleeplessness persists for more than 4 weeks (chronic insomnia) (Berardi et al. 2002: DiPiro et al. 2002).
Sources cited by Health Canada (2)
- Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA, Tietze KJ, editors. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13th edition. Washington (DC): American Pharmaceutical Association; 2002.
- DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM. Pharmacotherapy: A Pathophysiological Approach, 5th edition. New York (NY): McGraw-Hill Co. Inc.; 2002
Condition of application: Restlessness/nervousness.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condition of application: All uses.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (EMA 2014).
Sources cited by Health Canada (1)
- EMA 2014. European Medicines Agency. Community Monograph on. London (UK): EMEA Committee on Herbal Medicinal Products (HMPC), 20 September 2016. [Accessed 2023 October 1]. Available from: https://www.ema.europa.eu/documents/herbal-summary/passion-flower-summary-public_en.pdf
When using this product avoid taking with alcohol or products that cause drowsiness (EMA 2014; Brinker 2010).
Sources cited by Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- EMA 2014. European Medicines Agency. Community Monograph on. London (UK): EMEA Committee on Herbal Medicinal Products (HMPC), 20 September 2016. [Accessed 2023 October 1]. Available from: https://www.ema.europa.eu/documents/herbal-summary/passion-flower-summary-public_en.pdf
When using this product exercise caution if you drive or use machinery as you may experience drowsiness (EMA 2014).
Sources cited by Health Canada (1)
- EMA 2014. European Medicines Agency. Community Monograph on. London (UK): EMEA Committee on Herbal Medicinal Products (HMPC), 20 September 2016. [Accessed 2023 October 1]. Available from: https://www.ema.europa.eu/documents/herbal-summary/passion-flower-summary-public_en.pdf
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (EMA 2014).
Sources cited by Health Canada (1)
- EMA 2014. European Medicines Agency. Community Monograph on. London (UK): EMEA Committee on Herbal Medicinal Products (HMPC), 20 September 2016. [Accessed 2023 October 1]. Available from: https://www.ema.europa.eu/documents/herbal-summary/passion-flower-summary-public_en.pdf
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Brand : Herb Pharm Herbs on the Go
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Bed Time : étiquette retirée du marché américain (Herb Pharm Herbs on the Go): composition and French regulation”, https://compoatlas.com/en/supplements/us-labels/90700032104-bed-time-herb-pharm-herbs-on-the-go, updated 22 February 2024.